Evidence map›Paper›PMID 28076796›Full record

ArticleCell reports2017

Ribosomal Proteins Rpl22 and Rpl22l1 Control Morphogenesis by Regulating Pre-mRNA Splicing.

Yong Zhang, Monique N O'Leary, Suraj Peri, Minshi Wang, Jikun Zha, Simon Melov, Dietmar J Kappes, Qing Feng, Jennifer Rhodes, Paul S Amieux and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Chromatin topology control by a muscle-specific ribosomal protein.bioRxiv : the preprint server for biology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Ribosomal protein paralogues in ribosome specialization.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  15. Review
  16. Article
  17. High-resolution reconstruction of aRNA (New York, N.Y.) · 2024
    Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Yong ZhangBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Monique N O'LearyBuck Institute for Research on Aging, Novato, CA 94945, USA.
Suraj PeriBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Minshi WangBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Jikun ZhaBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Simon MelovBuck Institute for Research on Aging, Novato, CA 94945, USA.
Dietmar J KappesBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Qing FengFred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Jennifer RhodesBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Paul S AmieuxDepartment of Pharmacology, University of Washington, Seattle, WA 98195, USA.
David R MorrisDepartment of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Brian K KennedyBuck Institute for Research on Aging, Novato, CA 94945, USA.
David L WiestBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. Electronic address: david.wiest@fccc.edu.
Fox Chase Cancer Center · USBuck Institute for Research on Aging · USUniversity of Washington · USFred Hutch Cancer Center · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
University of Texas M.D. Anderson Cancer SPORE-LeukemiaP50CA100632 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KONOPLEVA, MARINA Y · 2003 to 2023
$43.7M
TRAINING PROGRAM IN CANCER RESEARCHT32CA009035 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 1985 to 2020
$10.5M
Regulation of hematopoiesis by ribosomal protein paralogsR37AI110985 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI DAVID L. WIEST · 2020 to 2026
$4.2M
Regulation of Hematopoiesis by Ribosomal Protein ParalogsR01AI110985 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI WIEST, DAVID L. · 2015 to 2019
$2.0M
Regulation of Hematopoiesis By Ribosomal Protein ParalogsR56AI110985 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI WIEST, DAVID L. · 2014 to 2014
$446k
NCI NIH HHS P30 CA006927NCI NIH HHS P50 CA100632NCI NIH HHS T32 CA009035NIAID NIH HHS R01 AI110985NIAID NIH HHS R37 AI110985NIAID NIH HHS R56 AI110985
6 · The paper itself

Abstract

Most ribosomal proteins (RP) are regarded as essential, static components that contribute only to ribosome biogenesis and protein synthesis. However, emerging evidence suggests that RNA-binding RP are dynamic and can influence cellular processes by performing "extraribosomal," regulatory functions involving binding to select critical target mRNAs. We report here that the RP, Rpl22, and its highly homologous paralog Rpl22-Like1 (Rpl22l1 or Like1) play critical, extraribosomal roles in embryogenesis. Indeed, they antagonistically control morphogenesis through developmentally regulated localization to the nucleus, where they modulate splicing of the pre-mRNA encoding smad2, an essential transcriptional effector of Nodal/TGF-β signaling. During gastrulation, Rpl22 binds to intronic sequences of smad2 pre-mRNA and induces exon 9 skipping in cooperation with hnRNP-A1. This action is opposed by its paralog, Like1, which promotes exon 9 inclusion in the mature transcript. The nuclear roles of these RP in controlling morphogenesis represent a fundamentally different and paradigm-shifting mode of action for RP.

Indexed as

MorphogenesisAnimalsEmbryo, MammalianEmbryo, NonmammalianExonsGastrulationGene Expression Regulation, DevelopmentalGene Knockdown TechniquesHeterogeneous Nuclear Ribonucleoprotein A1Mice, Inbred C57BLRibosomal ProteinsRNA-Binding ProteinsRNA, MessengerRNA PrecursorsRNA SplicingSmad2 ProteinHeterogeneous Nuclear Ribonucleoprotein A1Ribosomal ProteinsRNA-Binding ProteinsRNA, MessengerRNA PrecursorsRPL22L1 protein, mouseRpl22l1 protein, zebrafishRPL22 protein, mouseRpl22 protein, zebrafishSmad2 ProteinZebrafish Proteinsextraribosomal functiongastrulationhnRNP-A1morphogenesisparalogpre-mRNA splicingribosomal proteinRpl22Rpl22l1Smad2

Identifiers

PMID28076796
PMCPMC5234864
OpenAlexW2567964444

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.